Reply to: Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure

  1. Pérez-Belmonte, L.M.
  2. Miramontes-González, J.P.
  3. Osuna-Sánchez, J.
  4. Lara, J.P.
  5. Gómez-Huelgas, R.
Aldizkaria:
Journal of the American Geriatrics Society

ISSN: 1532-5415,  0002-8614

Argitalpen urtea: 2022

Alea: 70

Zenbakia: 5

Orrialdeak: 1585-1589

Mota: Gutuna

DOI: 10.1111/JGS.17703 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus